GAIL BOUDREAUX
CIK 1287920 · President and CEO · last filed 2026-03-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$68.48M
Companies
9
Total Filings
139
Lifetime Open-Market Net
-$37.02M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TGT | Director | 12,192 | $135.23 | $1.65M | $0 | 6 | 2026-03-13 |
| ELV | President and CEO | 160,520 | $404.07 | $64.86M | -$14.59M | 7 | 2026-03-04 |
| Elevance Health, Inc. (ANTM) Delisted | President and CEO | 94,041 | $482.58 | $45.38M | $2.00M | 6 | 2022-03-03 |
| ZIMMER BIOMET HOLDINGS, INC. (ZMHw) Delisted | Director | 2,095 | — | — | $250.0K | 41 | 2021-04-02 |
| ANTX | President and CEO | 11,104 | $4.74 | $52.6K | $0 | 1 | 2018-03-05 |
| XEL | Director | 1,780 | $79.22 | $141.0K | $50.0K | 29 | 2018-01-02 |
| NVAX | Director | 200,000 | $8.88 | $1.78M | $144.8K | 4 | 2017-03-20 |
| UNITEDHEALTH GROUP INC (UNHw) Delisted | EVP & CEO, UnitedHealthcare | 184,731 | — | — | -$24.88M | 39 | 2014-09-25 |
| GENZYME CORP (GENZ) Delisted | Director | 5,000 | — | — | $0 | 6 | 2011-04-06 |
Recent Filings · Page 2 of 14
139 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-11-04 | ELV | Gift (G) | −10,000 | $0 | EDGAR |
| 2022-03-10 | TGT | Grant (A) | +1,432 | $0 | EDGAR |
| 2022-03-03 | Elevance Health, Inc. (ANTM) Delisted | Mixed | +19,501 | -$7.69M | EDGAR |
| 2021-09-24 | TGT | Grant (A) | +514 | $0 | EDGAR |
| 2021-04-02 | ZIMMER BIOMET HOLDINGS, INC. (ZMHw) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-03 | Elevance Health, Inc. (ANTM) Delisted | Mixed | +46,627 | -$11.59M | EDGAR |
| 2021-01-05 | ZIMMER BIOMET HOLDINGS, INC. (ZMHw) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-02 | Elevance Health, Inc. (ANTM) Delisted | Tax (F) | −14,764 | -$4.63M | EDGAR |
| 2020-10-02 | ZIMMER BIOMET HOLDINGS, INC. (ZMHw) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-02 | ZIMMER BIOMET HOLDINGS, INC. (ZMHw) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.